(Circulation. 1995;92:442-449.)
© 1995 American Heart Association, Inc.
Articles |
Isolated Congenital Complete Atrioventricular Block in Adult Life
A Prospective Study
From the Section of Pediatric Cardiology, Department of Pediatrics, University Hospital, Uppsala, Sweden.
Correspondence to Dr Magnus Michaëlsson, Section of Pediatric Cardiology, Department of Pediatrics, University Hospital, 751 85 Uppsala, Sweden.
 |
Abstract |
|---|
 Top Abstract IntroductionMethods Results Discussion References |
|---|
Background The prognosis of congenital complete atrioventricular block (CCHB) is usually considered favorable in adults. This belief is based on studies comprising a limited number of patients and with rather short observation times. In the present study, the natural history of the disease was investigated by a prospective follow-up through decades of adult life of patients with a large group having well-defined CCHB without structural heart disease.
Methods and Results The diagnostic criteria of CCHB proposed by Yater were applied. Patients registered as having CCHB in 1964, supplemented by younger patients all without symptoms during their first 15 years of life, were selected. The study was limited to patients with isolated, complete, permanent block. An interview was conducted with all patients and clinical follow-up data obtained. There were finally 102 patients, 61 women and 41 men. In November 1994, the time of observation, after the age of 15 years in survivors, was between 7 and 30 years. The mean age at follow-up or at death was 38 years, median age 37 years, and range 16 to 66 years. Stokes-Adams (SA) attacks occurred in 27 patients, in 8 with a fatal outcome. The first attack was fatal in 6 of these 8 patients. Nineteen survived and a pacemaker (PM) was implanted thereafter. Another 8 patients received a PM because of repeated fainting spells, and 27 others have had a PM implanted for other reasons such as fatigue, effort dyspnea, dizziness, ectopies during exercise tests, mitral regurgitation, and a low ventricular rate (VR). VR decreased with age, with a mean rate at 15 years of 46 beats per minute (bpm), at 16 to 20 years of 43 bpm, at 21 to 30 years of 41 bpm, at 31 to 40 years of 40 bpm, and after 40 years of age of 39 bpm. SA attacks occurred in all 7 patients with prolonged QTc time. Low VR at rest or at work, presence of bundle-branch block pattern, low working capacity, and ectopies at rest and/or during effort were not statistically significant risk factors. SA attacks occurred in 6 patients without any of these signs. Mitral regurgitation developed in 16 patients and 4 died. A PM reduced the risk of death. A change to a lower degree of block occurred in 6 patients.
Conclusions Prophylactic PM treatment is recommended even for symptom-free adults with CCHB because of the high incidence of unpredictable SA attacks with considerable mortality from first attacks, a gradually decreasing VR, significant morbidity, and a high incidence of "acquired" mitral insufficiency.
Key Words: mitral insufficiency • pacemakers
|
Introduction |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Several publications have described the natural history in infancy and childhood of congenital complete atrioventricular block (CCHB) with and without structural heart disease.1 2 3 4 5 6 7 8 9 10 The signs and symptoms indicating a need for pacemaker (PM) treatment are now more or less well established.11 The outcome of CCHB in adults is less well known, as reflected in the different attitudes regarding PM treatment. This is evidently because studies covering adult life are few, with small numbers of patients, and rarely prospective. An optimistic report was published in 1966, based on 6 cases followed up for 34 to 40 years.12 Another recent report stated that "the main indication for PM implantation was symptoms alone."13 Other publications indicate a less favorable outcome.2 3 10 14 15 Our own interest dates back to 1963, with the experience of repeated Stokes-Adams (SA) attacks in a previously asymptomatic 15-year-old girl.16
A joint study on the natural history of CCHB was started in 1964 by members of the Association of European Paediatric Cardiologists, and a similar study was begun in 1967 in North America.3 5 6 In the late 1970s a follow-up of Swedish cases in adult life was carried out.14 This material has been reexamined, updated, and extended and forms the basis of the present report.
The aim of the study was to answer the following questions: What is the long-term natural history of a patient with CCHB who is asymptomatic in infancy and childhood? Can SA attacks be predicted in the patient? Do other symptoms or signs appear later in life?
|
Methods |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
The diagnostic criteria of congenital heart block proposed by Yater17 were applied, namely: "Heart block established in a young patient by graphic records. There must be some evidence of the existence of the slow pulse at a fairly early age and absence of a history of any infection which might cause the condition after birth: notably diphtheria, rheumatic fever, chorea and congenital syphilis." The ECG criteria used are: the atria and ventricles should be completely dissociated, the ventricular rate (VR) should be slower than the atrial rate, and no captured beats should be present.
A registry of patients known in 1964 was gradually supplemented with younger patients when they had passed the age of 15 years without symptoms. The hospital records, including ECG tracings and, in the event of death, the autopsy findings, were studied.
A number of cases not strictly following the above-mentioned criteria were excluded. Examples are: patients in whom an occasional ECG recording showed captured beats; suspicion of endomyocarditis early in life; and diagnosis delayed until late childhood. All patients with a suspicion of associated congenital heart disease such as atrioventricular inversion, atrial septal defect, or persistent ductus arteriosus were excluded. Patients with symptoms such as fainting spells in childhood were also omitted.
In this way, 30 heart block patients were excluded. Among these, 6 had died: 1 woman from breast cancer at the age of 68, another woman with malignant melanoma at the age of 38, and the other 4 (2 women and 2 men) suddenly and unexpectedly at the ages of 15, 31, 43, and 46 years. Thus, these 30 patients are not included elsewhere in this presentation.
Study Group
The final group consisted of 102 patients, 61
women and 41 men.
All patients could be traced, and up-to-date information was collected
from the hospitals and from the patients. A low heart rate had been
found and CCHB had been diagnosed in utero or by ECG in the neonatal
period in 51 cases: before the age of 1 year in 9, between the ages of
1 and 5 years in 20, between 6 and 10 years in 15, and between 11 and
15 years of age in 7 cases. For evident reasons, the older patients are
overrepresented in the groups with delayed ECG verification
of the block. Repeated ECG recordings during infancy and
childhood confirmed that the block was permanent and complete. A QRS
complex of 0.12 second or wider was named "widened QRS complex."
A QTc time of more than 0.45 second was named prolonged
QTc.
Data and recordings from physical working capacity tests were available in 86 cases. The tests were performed on an electrically braked bicycle ergometer with an increasing load, either in 6-minute periods or with shorter intervals. The work was carried out either to submaximal or to maximal capacity. Oxygen uptake and lactate levels were determined in a few patients only. The results of the last exercise test are expressed as the VR during maximal work performed (W/kg body wt). Data on the occurrence of ventricular ectopy during effort were recorded and compared with the natural history. Chest radiographic and echocardiographic information was not systematically collected.
Statistical Analysis
Data were analyzed using categorical
data analysis
models. The Catmod procedure of the SAS (1990) package was
used.18 Presence or absence of a symptom was coded as 1 or
0, respectively. Continuous variables such as age and heart rate
were included as such in the models by using the DIRECT statement.
|
Results |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
The age at the last follow-up or the age at death of the entire cohort of patients is presented in Fig 1
, where
the age at PM implantation is also indicated. The mean age at follow-up
or at death was 38 years, median age 37 years, and range 16 to 66
years. The youngest living patient is 22 years old, so the shortest
observation time after the age of 15 is 7 years. Of 32 living patients
over the age of 45 years, 28 have a PM.
|
The age at death, syncope, or presyncope in 37 patients is
presented in Fig 2. The attacks could apparently
occur at any age with no preferential period.
|
There were 11 deaths. One man committed suicide at the age of 19 years. A few months earlier he had refused PM treatment recommended because of a low VR and an increasing size of the left ventricle. Four patients, men aged 24, 31, and 45 years and a 43-year-old woman, died after PM implantation. The indication for PM was syncope in 3 patients and heart failure in 1 patient; the cause of death in 2 was PM failure (generator depletion and lead fracture, respectively), and the other 2, who both died during sleep, were in heart failure and were waiting for surgery for mitral insufficiency. The other 6 patients died suddenly without any preceding symptoms. Autopsy was performed on 5 of these 6 patients, and no other cause of death was disclosed. Nineteen other patients had syncope attacks and survived, 6 of them after cardiac resuscitation. They all had a PM implanted afterward. Another 8 patients had repeated fainting spells and are on PM treatment.
In a number of cases the circumstance preceding syncope or death were known. Five patients died during sleep. Two had their attacks after micturition, 5 when resting after physical effort, and 4 in orthostatic situations (standing up after a medical examination, hanging up washing, waiting at a bus stop, and during an orthostatic test). Three patients had their SA attacks during pregnancy, 1 of them during anesthesia for planned cesarean section. No patient had syncope episodes during physical effort. Chest pain sensations were noted before the attacks in no fewer than 11 patients. Easy fatigability, nightmares, and psychical alterations were common findings preceding the attacks. Eight patients were treated with sedatives for anxiety and nervousness, probably caused by syncope sensations related to a slow VR. Mitral insufficiency was noted before the attacks in 4 patients.
The initial phase of the SA attack was documented on ECG in 5 patients. A 15-year-old girl had repeated episodes of ventricular arrest, starting every time with one ventricular ectopic beat. On two occasions the period of ventricular arrest turned into ventricular tachycardia. The same series of events occurred in a 37-year-old woman. Three other women of ages 21, 22, and 34, respectively, had periods of ventricular arrest without preceding ventricular ectopy. The 34-year-old woman had the arrest during anesthesia and the arrest was followed by ventricular fibrillation. In 4 of these patients, QTc was prolonged at the time of the attacks.
Other Symptoms
Easy fatigability and effort dyspnea,
increasing with age, were
the dominant symptoms in 16 cases. Three patients developed cardiac
failure, the two men with mitral insufficiency mentioned above and a
56-year-old woman who had been treated with a PM for 13 years. She had
a low cardiac output and effort dyspnea before PM implantation and has
developed heart failure during the last few years.
Other Diseases
Three patients had kyphoscoliosis, 2 had
diabetes mellitus, and 12
had moderate systemic hypertension; 9 of these hypertensive patients
were more than 50 years old. Two women, 26 and 34 years old, had
collagen disease. Hypothyroidism after pregnancy was present in 2
women. One man was operated on for goiter, and the
histological picture showed no signs of
thyrotoxicosis.
Mitral Insufficiency
Mitral insufficiency developed in 16
patients, 8 women and 8 men.
In 6 of these patients the CCHB was diagnosed before or at birth. In 6
patients the diagnosis of regurgitation was established
by means of physical examination only and in the other 10 patients by
ultrasound and/or angiocardiography in addition. No patient had a
history of rheumatic fever. The insufficiency was mild in 9 patients
and moderate or severe in 7 patients. Two patients underwent surgery,
one at the age of 22 years (annuloplasty) and the other at the age of
21 years (valve replacement). The age at the first appearance of
insufficiency varied between 13 and 56 years (median age at onset, 33
years). One man had effort dyspnea during his last year of life and
died suddenly at the age of 57 years, having not been treated with a
PM. The other 15 patients received a PM. In 8 patients the main
indication for PM was SA attacks (6) or presyncope (2). After the PM
implantation, no significant signs of further deterioration of the
valve disease were noted in 11 of the patients. The
regurgitation disappeared after PM implantation in one
case. Three men died 8 months, 6 months, and 1 week after implantation
of PM at the ages of 24, 31, and 45 years, respectively. Two of these
patients were in severe heart failure, and the 24-year-old man died
after repeated SA attacks. The autopsy of this patient showed lead
fracture. Autopsy of the 31-year-old man showed dilated mitral annulus
and fibrosis of the left ventricle. The autopsy findings of the
45-year-old man showed dilated annulus, fibrosis, and signs of a fresh
myocardial infarction of the left ventricle. This man had a history of
mitral regurgitation for 3 months and died 1 week after
PM implantation. There was a positive correlation (P<.001)
between SA attacks and mitral regurgitation.
ECG Findings
VR and Atrial Rate at Rest
The
mean VR in women was 42 beats per minute (bpm) and in men, 41
bpm. Fig 3 shows the VR and atrial rate (AR) in the
material as related to age. Patients with a change of rhythm are not
included. Repeated ECG recordings allowing a comparison of the
individual VR with increasing age were available in 94 patients. A
decrease in VR was noted in 76 patients. The VR was unchanged in 11
patients and in 7 patients it increased. In the group of 29 patients
with syncope and presyncope, 17 patients had a VR <40 bpm at the
recording immediately before the attack, but statistically low
VR was not significantly correlated with future SA attacks or death.
The decrease in VR with age was statistically significant
(P<.0025).
|
Atrial Flutter-Fibrillation
Atrial tachydysrhythmias were noted in 4 patients with mitral
insufficiency at the ages of 53, 46, 45, and 40 years, respectively.
Two patients died. Atrial flutter was observed at the age of 8 years in
another patient. She received a PM for SA attacks at the age of 30
years.
Change of Rhythm
The puzzling event of an
apparently permanent complete
atrioventricular (AV) block changing into a lower
degree of block occurred in 6 patients (Table 1).
Otherwise, these patients did not differ from the other patients
reported. In 5 of the cases the block had changed to first-degree AV
block and in 1 case to second-degree block. This latter patient was 26
years old, and the block was diagnosed in utero. Her mother had
lupus erythematosus, and she herself had
rheumatoid arthritis. None of these 6 patients had bundle-branch block
pattern.
|
Wide QRS Escape Rhythm
Eight of 102
patients had widened QRS complexes: 4 had right
bundle-branch block (RBBB) pattern, 1 with left anterior hemiblock in
addition and another 4 patients had left bundle-branch block (LBBB)
pattern. Two patients with RBBB and 1 with LBBB pattern had SA attacks,
at the ages of 57, 22, and 16 years. The youngest patient showed a poor
VR response to exercise when 10 years old, with an increase in VR from
40 to 55 bpm at a workload of 2.5 W/kg. The other 5 BBB cases have no
symptoms and no PM so far and are 46, 41, 37, 27, and 26 years old. The
maximal VR during exercise tests in these patients were 109, 102, 92,
93, and 74 bpm. In this group of patients only sporadic ectopic beats
appeared during exercise. The presence of widened QRS complexes was
statistically no predictor of SA attacks and/or death.
QT
Time
A prolonged QT time (QTc >0.45 second) was
recorded on one or more occasions in 7 out of 102 patients (Table
2). In all cases, a normal QTc time had
previously been observed. SA attacks occurred in all 7 patients. The
prolonged QTc times were noted after the attack in 3
patients—12 hours, 14 days, and 3 weeks after, respectively. In 4
patients the SA attacks occurred after the recording of
prolonged QTc. The time interval varied between 6 months
and 5 years. Three patients died, 1 from the attack and 1 from brain
damage caused by the circulatory arrest. The third patient with
repeated SA attacks had mitral insufficiency in addition and died 8
months after PM implantation. The other 4 patients have survived
without symptoms and with PM treatment for 23, 21, 18, and 17 years,
respectively. The ECG with prolonged QTc showed a lower VR
than earlier recordings, and 6 patients had rates of 
40
bpm.
|
Exercise Tests
Data from exercise tests are
presented in Fig 4. The 6 patients in whom the CCHB changed
from complete
to grade I or II have been excluded. The remaining 81 patients have
been divided into 34 with a workload of less than 2 W/kg and 47 with a
workload of 2 W/kg or more. In the group with a lower workload there
are 7 patients with a VR increase of 25 bpm, compared with 2 patients
in the group with a higher workload. The mean VR increase was 90 bpm in
the lower workload group, with a range of 55 to 136 bpm, and in the
group with the higher workload it was 115 bpm, with a range of 55 to
155 bpm. Resting VRs of <40 bpm were noted in 15 patients, and 7 of
these had SA attacks later. There were 17 patients with a VR during
exercise of <80 bpm, and in 8 of them SA attacks occurred.
Ventricular ectopies were found to disappear during heavier
workload in 8 patients, and only 1 had future SA attacks. In 22
patients ectopies were frequent and increased with a heavy workload. In
this group 13 subsequently had syncope or presyncope. As many as 11
patients with future syncope attacks had an exercise test with a
resting VR >40 bpm, a VR increase >80 bpm, and no ectopy. No
significant statistical correlation was found between VR at rest or
during effort, low working capacity or ectopies, and future SA attacks
and/or death.
|
2 W/kg. Black dots mark frequent ectopies and arrows mark
future sudden death, syncope, and presyncope.
Pacemaker Treatment
A total of 54 patients were treated with
PMs (Fig 1
). The
indications were syncope or presyncope in 27 patients. The indications
for the remaining patients were general fatigue, effort dyspnea,
dizziness, and, in 16 cases, also low VRs. Four of these had mitral
insufficiency. Three patients, aged 21, 21, and 17 years, respectively,
received their PMs mainly because of a low VR and frequent ectopies
during effort. One patient, aged 22 years, was given a PM during
pregnancy because of toxemia of pregnancy. The median age of the other
23 patients at time of implantation was 34 years and the range, 16 to
49 years.
Two patients with a failing PM died suddenly in 1967 (lead fracture) and 1978 (generator depletion), 8 months and 13 years, respectively, after PM implantation. Other serious PM complications were thrombosis of the superior vena cava in one case and endocarditis involving the tricuspid valve in another case. Two other patients with mitral regurgitation and severe heart failure died suddenly, 6 months and 1 week, respectively, after PM implantation, but no evidence of PM failure was disclosed. Age-related statistical analysis showed that the mortality was significantly lower in patients with a PM implanted (P<.03). The pacing therapies changed over the years in the same patient and from case to case. It is therefore not possible to evaluate the different techniques in this material.
Pregnancy
Twenty-four women without a PM gave birth, to 45
children in
total. Three of these 24 had syncope attacks during pregnancy, and a PM
was implanted in 2 women. Three other patients had fainting spells
during pregnancy, and another 3 noted dizziness after delivery. One
woman with toxemia of pregnancy had prophylactic PM
implantation. Eight other women with a PM had uneventful pregnancies
and deliveries of a total of 14 children.
Thirty-Year Follow-up
Forty of the 102 patients were already
registered 30 years ago.
The mean age at that time was 22 years, with a range of 15 to 44 years.
During these 30 years, 8 patients died. The mean age at death was 42
years, with a range of 24 to 58 years. Fifteen patients survived SA
attacks (12) or fainting spells (3) and received a PM. Another 13
patients received a PM for other reasons (dyspnea, low working
capacity, mitral regurgitation). Twelve patients
developed mitral regurgitation. Only 4 patients (52,
50, 49, and 47 years old) are free from symptoms and do not have a PM.
In 2 of these patients the block has changed to a first-degree AV
block. The natural history of these patients is further illustrated in
Fig 5.
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
Cases of associated structural heart disease have been omitted in this study and no patients with symptoms in infancy or childhood are included. The prognosis should therefore be better than in any other patients with CCHB. The finding of high mortality and morbidity rates in both young and older adults supports a much less optimistic view than has previously been held. Many of the patients were told when they were young that no further examinations were necessary "unless you became symptomatic." This attitude is unwise, since deterioration both without symptoms and with symptoms not readily referable to the dysrhythmia, such as anxiety and mental confusion, was noted. Among the 48 patients who were not treated with a PM, the first SA attack was fatal in no fewer than 6 cases. Among the 54 patients who had a PM implanted, there were 4 deaths, 2 due to PM failure and 2 due to myocardial infarction and heart failure. We conclude that a reduction of mortality could have been achieved if PMs had been implanted earlier in life.
Risk Criteria
It could be argued that cases not diagnosed
before or at birth
should not be classified as "congenital." In half of the
present patients, CCHB was diagnosed in utero or at birth. With 12
cases having SA attacks in this "truly congenital" group, as
compared with 15 among the patients diagnosed later, the age at
diagnosis does not seem to be of prognostic importance.
It would be
desirable to be able to point out signs predicting an
increased risk in the individual patient. Low VRs—<40 bpm in the
young, 35 bpm in the elderly—prolongation of the QT time and the
appearance of frequent ectopies, as well as a low VR response during
heavy work, have been reported as such
indicators.11 19 20 21 22
There are several examples among these patients of syncope attacks
occurring without any preceding signs. The only convincing risk factor
in this study was a prolonged QTc. All 7 patients with a
prolonged QTc suffered SA attacks.
Stokes-Adams Attacks
The term SA attack is not always clearly
defined. According to
Stokes' own description, fainting spells can be looked upon as
less-severe SA attacks. He wrote: "In some there is a momentary
unsteadiness in walking and in others a tendency to faint; while in the
more decided cases the patient becomes suddenly comatose." In this
study, the patients with fainting spells are described as a group
separated from "the more decided cases."
It is of interest to note that SA attacks never occurred during effort. Many patients stated that they felt better during physical activity than at rest, probably because of the higher VR during effort. Retardation of VR, exit block, during sleep as described by Levy et al19 might be the reason why 5 patients died during sleep. Very low VRs could explain why nightmares are so common in CCHB patients.
Ventricular Rate
It is well known that in CCHB the VR
decreases with age during
infancy and childhood. The decrease in VR in adults is to our knowledge
a new observation. The AR did not decrease with age. We have no
explanation for the decrease in VR, but it must reduce the ability to
maintain an adequate cardiac output. It might be of interest to note
that no age-related heart rate changes can be demonstrated in adults
with sinus rhythm.23
Mitral Regurgitation
Only 2 cases of CCHB with mitral valve
involvement have been
described previously. One was a 16-year-old boy reported in a follow-up
study,14 and the other was a 41-year-old woman in whom the
mitral insufficiency was ascribed to a prolapsing mitral
valve.24 In the present study, none of the 16 patients
showed evidence of valvular lesions early in life. A lower VR
was a frequent finding in this group of patients. It is possible that a
very low VR with overdistension of the left ventricle and the papillary
muscles caused the valve regurgitation. Another
conceivable hypothesis is that mitral insufficiency is the long-term
result of more extensive immunopathological damage to the fetal heart.
The regurgitation is more common in the elderly
patients. The risk of acquiring mitral insufficiency, with its
deleterious consequences, in CCHB is a strong argument for PM treatment
early in life.
Wide QRS Escape Rhythm
A BBB pattern, in contrast to narrow
QRS complexes, is believed to
imply a poor long-term prognosis. The findings in this study offer
limited support to this hypothesis, 3 out of 8 BBB cases having SA
attacks. On the other hand, 2 of the patients with a BBB pattern died
in their first attack.
Exercise Tests
A recent publication on the cardiorespiratory
response to
exercise in CCHB includes a literature review.25 The
authors state that neither the individual exercise response nor the
exercise tolerance could be predicted from the resting VR and also that
the VR response was below the 95% confidence limit throughout
different exercise levels. The occurrence of a low VR at rest, a poor
VR response, and the occurrence of ectopies during heavy work have been
reported as poor prognostic signs.23 Our study could not
confirm these findings. In fact, 7 patients with future SA attacks had
a VR at rest of >40 bpm, a satisfactory VR response, and no ectopy.
When the VR response is compared with the exercise performance,
a tendency toward a better response with heavier exercise is noted. Our
research does not allow more detailed analysis in this respect.
Determination of the ventilatory threshold would probably have been
helpful in the assessment of the functional
capacity.25
QTc Prolongation
The present study confirms that
prolongation of the
QTc time is an unfavorable prognostic
sign.21 22 A prolonged QTc time associated
with CCHB has been described as a separate disease entity, and
ß-receptor blocking has been recommended together with PM
treatment.25 Another speculation is that a prolonged
QTc time is a sign of myocardial damage rather than a
separate syndrome. In their study concerning prolongation of the
QTc time as a predictor of sudden death in myocardial
infarction, Schwartz and Wolf26 assume that local
myocardial damage might be responsible for the QT prolongation.
Similarly, episodes of excessively low VR and/or some other unknown
factor might cause myocardial damage manifested by a longer
QTc. Six of the 7 patients with prolonged QTc
had VRs of 40 bpm at the time of ECG recording.
Change of Rhythm
It is difficult to imagine how a CCHB could
change into a
lower-degree block or even into sinus rhythm. Doubt could be raised if
the block cases
published12 14 27 28 29 30 31 32
and the ones here
reported—14 cases in all—are truly congenital: At least 4 of the
cases were diagnosed in utero or at birth. In that sense they are
congenital, and there is no indication that the other 10 cases were
different. The degree and extension of the morphological findings in
CCHB—fibrosis of the conductive system and other parts of the
heart—are very different from case to case. It is quite possible that
the morphological abnormalities in cases of CCHB changing in rhythm are
discrete and that the block could be explained in
electrophysiological terms such as decremental
conduction.33 In one of the patients, CCHB changed to AV
block I after many years of PM treatment for SA attacks.
Conclusions
Patients changing into a lower degree of block
are rare
exceptions. In a life-long perspective, CCHB is a potentially
life-threatening disease with significant morbidity in the group as a
whole. There is a risk of SA attacks and sudden death at any age even
in the absence of poor prognostic signs. It is possible that early PM
implantation reduces or eliminates morbidity such as mitral valve
insufficiency. We therefore recommend a PM to any adolescent patient
with CCHB.
If a PM should be refused, an annual examination is recommended, with Holter monitoring, exercise testing, and echocardiography. The occurrence of decreasing VR, a low rate response, or frequent ectopies during effort, exit block periods or ectopies during monitoring, mitral insufficiency, a long QTc time, and widened QRS complexes are all good reasons for discussing PM treatment again.
In summary: (1) 40 patients were followed for 30 years and only 4 remained free from symptoms and without a PM; (2) 11 of 102 patients died at a relatively young age; (3) SA attacks or fainting spells occurred in 35 patients, none during exertion; (4) mitral regurgitation developed in 16 patients; (5) the CCHB changed to a lower degree of block in 6 of the 102 patients; (6) VR decreased with age; (7) mitral regurgitation was a predictor of future SA attacks; (8) long QTc was strongly linked to SA attacks; (9) low VRs, widened QRS complexes, low exercise response, and ectopies were not predictive of future SA attacks or death; and (10) a PM reduces mortality.
|
Acknowledgments |
|---|
The authors are indebted to colleagues at the Departments of Medicine and Cardiology for their kind help and cooperation and for information received from the Swedish Pacemaker Registry. Ulf Olsson, Professor of Statistics, kindly assisted with the statistical analysis.
Received December 2, 1993; revision received June 19, 1995; accepted June 19, 1995.
|
References |
|---|
|
TopAbstractIntroductionMethods Results Discussion References |
|---|
1. Molthan ME, Miller RA, Hastreiter AR, Paul MH. Congenital heart block with fatal Adam-Stokes attacks in childhood. Pediatrics. 1962;30:32-41.
2. Nakamura FF, Nadas AS. Complete heart block in infants and children. N Engl J Med . 1964;270:1261-1268.
3. Michaelsson M, Swiderski J. High degree atrio-ventricular block in children. Proc Assoc Eur Paediatr Cardiol. 1967;3:44-49.
4. Kangos JJ, Griffiths SP, Blumethal S. Congenital complete heart block: a classification and experience with 18 patients. Am J Cardiol. 1967;20:632-638. [Medline] [Order article via Infotrieve]
5. Michaelsson M, Engle MA. Congenital complete heart block: an international study on the natural history. Cardiovasc Clin. 1972;4:85-98. [Medline] [Order article via Infotrieve]
6. Esscher E, Michaelsson M. Congenital complete AV block. In: Bayes A, Cosin J, eds. Diagnosis and Treatment of Cardiac Arrhythmias. Oxford, England: Pergamon Press; 1980:750-757.
7.
Reid JM, Coleman EN, Doig W. Complete
congenital heart block: report of 35 cases. Br Heart
J. 1982;48:236-239.
8.
Pinsky WW, Gillette PC, Garson A Jr, McNamara DG.
Diagnosis, management and long-term results of patients with
congenital complete atrio-ventricular block.
Pediatrics. 1982;69:728-733.
9. Sholler GF, Walsh EP. Congenital complete heart block in patients without anatomic cardiac defects. Am Heart J. 1989;118:1193-1198. [Medline] [Order article via Infotrieve]
10. Normand J, Bozio A, Heudron F, André M, Sassolas F, Jocteur-Monrozzier D, Bussilet H. Prognostic à long terme des blocs auriculo-ventriculaires congénitaux. Arch Mal Coeur Vaiss. 1992;85:14033-1409.
11. Smith RT. Pacemakers for children. In: Gilette PC, Garson A Jr, eds. Pediatric Arrhythmias: Electrophysiology and Pacing. Philadelphia, Pa: Saunders; 1990:532-558.
12. Campbell M, Emanuel R. Six cases of congenital heart block followed for 34-40 years. Br Heart J. 1966;59:587-590.
13. Pordon CM, Moodie DS. Adults with congenital complete heart block: 25-year follow-up. Cleve Clin J Med. 1992;59:587-590. [Medline] [Order article via Infotrieve]
14.
Esscher E. Congenital complete heart block in
adolescence and adult life: a follow up study. Eur Heart
J. 1981;2:281-287.
15. Camm AJ, Bexton RS. Congenital complete heart block. Eur Heart J. 1984;5(suppl A):115-117.
16. Michaelsson M, Pettersson PO. Pacemaker treatment for total, congenital (?) AV-block: report of a case. In: Proceedings of the 14th North Pediatric Congress. Acta Paediatr Scand. 1964;159(suppl):88.
17.
Yater WM. Congenital heart block: review of the
literature: report of a case with incomplete heterotaxy: the
electrocardiogram in dextrocardia. Am J
Dis Child. 1929;38:112-136.
18. SAS/Stat User's Guide, Version 6, 4th ed. Cary, NC: SAS Institute Inc; 1990.
19.
Levy AM, Camm AJ, Keane JF. Multiple
arrhythmias detected during nocturnal monitoring in patients
with congenital complete heart block.
Circulation. 1977;55:247-253.
20. Winkler RB, Freed MD, Nadas A. Exercise-induced ventricular ectopy in children and young adults with complete heart block. Am Heart J. 1980;99:87-92. [Medline] [Order article via Infotrieve]
21. Esscher E, Michaelsson M. Q-T interval in congenital complete heart block. Pediatr Cardiol. 1983;4:121-124. [Medline] [Order article via Infotrieve]
22.
Solti F, Szatmáry L, Vecsey T,
Rényi-Vámos F, Bodor E. Congenital complete heart
block associated with QT prolongation. Eur Heart J. 1992;13:1080-1083.
23. Spodic DH. Normal sinus heart rate: sinus tachycardia and sinus bradycardia redefined. Am Heart J. 1992;124:1119-1121. [Medline] [Order article via Infotrieve]
24.
Thomason HC, Miller AB, Hanson K.
Congenital complete atrioventricular block and
prolapsing mitral valve. Chest. 1976;70:539-542.
25. Reybrouck T, Van den Eynde B, Dumoulin M, Van der Hauwaert LG. Cardiorespiratory responses to exercise in congenital complete atrioventricular block. Am J Cardiol. 1989;64:896-899. [Medline] [Order article via Infotrieve]
26.
Schwartz PJ, Wolf S. QT interval prolongation as
predictor of sudden death in patients with myocardial
infarction. Circulation. 1978;57:1074-1077.
27. Gilchrist AR. Clinical aspects of high grade heart block. Scott Med J. 1958;3:53-75. [Medline] [Order article via Infotrieve]
28. Lenègre J, Deparis M, Auzépy R, Gay J. Deux cas (lún anatomoclinique) de bloc auriculo-ventriculaire probablement congénital et d'evolution régressive. Arch Mal Coeur. 1970;63:749-763.
29. Rytand DA, Stinson E, Kelly JJ. Remission and recovery from chronic, established, complete block. Am Heart J. 1976;91:645-652. [Medline] [Order article via Infotrieve]
30. Dewey RC, Capeless MA, Levy AM. Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete heart block. N Engl J Med. 1987;316:835-839. [Abstract]
31. Tsuji A, Yanai J, Komai T, Sato M, Saishi T, Fujuda T. Recovery from congenital complete atrioventricular block. Pediatr Cardiol. 1988;9:163-166. [Medline] [Order article via Infotrieve]
32.
Holdright DR, Sutton GC. Restoration of sinus
rhythm during two consecutive pregnancies in a woman with congenital
complete heart block. Br Heart J. 1990;64:338-339.
33. Ayers CR, Boineau JP, Spach MS. Congenital complete heart block in children. Am Heart J. 1966;72:381-389.[Medline] [Order article via Infotrieve]
This article has been cited by other articles:
 |
|
 |
|
  A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. Mark Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): 2085 - 2105. [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): 2820 - 2840. [Full Text] [PDF]
|
|
|
|
|
|
A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]
|
|
|
|
 |
|
 J P Buyon, A Brucato, and D M Friedman What's in a name? Ann Rheum Dis, May 1, 2008; 67(5): 732 - 732. [Full Text] [PDF]
|
|
|
|
 |
|
 D L Adamson and C Nelson-Piercy Managing palpitations and arrhythmias during pregnancy Postgrad. Med. J., February 1, 2008; 84(988): 66 - 72. [Full Text] [PDF]
|
|
|
|
 |
|
 D. L Adamson and C. Nelson-Piercy Managing palpitations and arrhythmias during pregnancy Heart, December 1, 2007; 93(12): 1630 - 1636. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Europace, October 1, 2007; 9(10): 959 - 998. [Full Text] [PDF]
|
|
|
|
 |
|
 Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295. [Full Text] [PDF]
|
|
|
|
|
|
G. C.M. Beaufort-Krol, Y. Stienstra, and M. Th.E. Bink-Boelkens Sinus node function in children with congenital complete atrioventricular block Europace, September 1, 2007; 9(9): 844 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Villain, N. Coastedoat-Chalumeau, E. Marijon, Y. Boudjemline, J.-C. Piette, and D. Bonnet Presentation and Prognosis of Complete Atrioventricular Block in Childhood, According to Maternal Antibody Status J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1682 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P.P. Smits, M. W. Veldkamp, and A. A.M. Wilde Mechanisms of inherited cardiac conduction disease Europace, January 1, 2005; 7(2): 122 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-B. Thambo, P. Bordachar, S. Garrigue, S. Lafitte, P. Sanders, S. Reuter, R. Girardot, D. Crepin, P. Reant, R. Roudaut, et al. Detrimental Ventricular Remodeling in Patients With Congenital Complete Heart Block and Chronic Right Ventricular Apical Pacing Circulation, December 21, 2004; 110(25): 3766 - 3772. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Rosen, P. R. Brink, I. S. Cohen, and R. B. Robinson Genes, stem cells and biological pacemakers Cardiovasc Res, October 1, 2004; 64(1): 12 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Guidelines on Management (diagnosis and treatment) of syncope - update 2004: The Task Force on Syncope, European Society of Cardiology Europace, January 1, 2004; 6(6): 467 - 537. [Full Text] [PDF]
|
|
|
|
 |
|
 A Brucato, A Jonzon, D Friedman, L D Allan, G Vignati, M Gasparini, J I Stein, S Montella, M Michaelsson, and J Buyon Proposal for a new definition of congenital complete atrioventricular block Lupus, June 1, 2003; 12(6): 427 - 435. [Abstract] [PDF]
|
|
|
|
|
|
Committee Members, G. Gregoratos, J. Abrams, A. E. Epstein, R. A. Freedman, D. L. Hayes, M. A. Hlatky, R. E. Kerber, G. V. Naccarelli, M. H. Schoenfeld, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) J. Am. Coll. Cardiol., November 6, 2002; 40(9): 1703 - 1719. [Full Text] [PDF]
|
|
|
|
|
|
G. Gregoratos, J. Abrams, A. E. Epstein, R. A. Freedman, D. L. Hayes, M. A. Hlatky, R. E. Kerber, G. V. Naccarelli, M. H. Schoenfeld, M. J. Silka, et al. ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines) Circulation, October 15, 2002; 106(16): 2145 - 2161. [Full Text] [PDF]
|
|
|
|
|
|
E. T. Jaeggi, R. M. Hamilton, E. D. Silverman, S. A. Zamora, and L. K. Hornberger Outcome of children with fetal, neonatal or childhood diagnosis of isolated congenital atrioventricular block: A single institution's experience of 30 years J. Am. Coll. Cardiol., January 2, 2002; 39(1): 130 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jonzon Congenital complete atrioventricular block. A pace in time saves lives (?) Europace, January 1, 2002; 4(4): 343 - 344. [PDF]
|
|
|
|
|
|
C. Balmer, M. Fasnacht, M. Rahn, L. Molinari, and U. Bauersfeld Long-term follow up of children with congenital complete atrioventricular block and the impact of pacemaker therapy Europace, January 1, 2002; 4(4): 345 - 349. [Abstract] [PDF]
|
|
|
|
|
|
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF]
|
|
|
|
|
|
Task Force on Syncope, European Society of Cardiol, M Brignole, P Alboni, D Benditt, L Bergfeldt, J.J Blanc, P.E Bloch Thomsen, J.G van Dijk, A Fitzpatrick, S Hohnloser, et al. Guidelines on management (diagnosis and treatment) of syncope Eur. Heart J., August 1, 2001; 22(15): 1256 - 1306. [Abstract] [PDF]
|
|
|
|
|
|
P Mazeika Aborted sudden cardiac death: a clinical perspective Postgrad. Med. J., June 1, 2001; 77(908): 363 - 370. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Eronen, M.-K. Sirèn, H. Ekblad, T. Tikanoja, H. Julkunen, and T. Paavilainen Short- and Long-Term Outcome of Children With Congenital Complete Heart Block Diagnosed In Utero or as a Newborn Pediatrics, July 1, 2000; 106(1): 86 - 91. [Abstract] [Full Text]
|
|
|
|
|
|
N. J. Kertesz, R. A. Friedman, S. D. Colan, E. P. Walsh, R. J. Gajarski, P. S. Gray, R. Shirley, and T. Geva Left Ventricular Mechanics and Geometry in Patients With Congenital Complete Atrioventricular Block Circulation, November 18, 1997; 96(10): 3430 - 3435. [Abstract] [Full Text]
|
|
|
|
 |
|
 ``Benign'' Prognosis for Congenital Complete AV Block? Journal Watch Cardiology, September 1, 1995; 1995(901): 3 - 3. [Full Text]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||